Literature DB >> 2081717

A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.

L J Piddock1, E A Traynor, R Wise.   

Abstract

Twenty five strains of Enterobacteriaceae (five each of Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii and Providencia stuartii) were exposed to aztreonam and ceftazidime at 1/2 and 1 x MIC in liquid medium for 22 h, and also to 3, 5 and 10 x MIC and 16 mg/l of each agent in agar. Any putative mutant with an increase in the MIC of greater than or equal to 4 fold was examined for beta-lactamase expression and outer membrane protein profile. Mutants were selected on agar at approximately 10(7); however in liquid medium not all strains yielded mutants. Mutants lacking an outer membrane protein (OMP) with a molecular weight of 40,000 (+/- 5000) were selected with both agents, as were mutants expressing constitutive Richmond and Sykes Class 1 beta-lactamase. For the Ent. cloacae mutants increased beta-lactamase gave rise to MICs above the breakpoint of both agents, whereas with the other species ceftazidime susceptibility was more affected. Strains that were OMP- rarely had MICs above the breakpoint, unless there was also increased beta-lactamase expression, as in species such as M. morganii. Hence the major mechanism of resistance in these strains would appear to be beta-lactamase mediated rather than due to altered expression of outer membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081717     DOI: 10.1093/jac/26.6.749

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.

Authors:  J Silva; R Gatica; C Aguilar; Z Becerra; U Garza-Ramos; M Velázquez; G Miranda; B Leaños; F Solórzano; G Echániz
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Authors:  L J Piddock; M C Hall; F Bellido; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.

Authors:  L J Piddock; M Zhu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients.

Authors:  L J Piddock; D J Griggs; M C Hall; Y F Jin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.

Authors:  P Heisig; R Tschorny
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.

Authors:  I García; A Pascual; M C Guzman; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis.

Authors:  L Leibovici; A J Wysenbeek; H Konisberger; Z Samra; S D Pitlik; M Drucker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

9.  Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.

Authors:  L J Piddock; H L Turner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

10.  The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella.

Authors:  Vito Ricci; Nick Loman; Mark Pallen; Alasdair Ivens; Maria Fookes; Gemma C Langridge; John Wain; Laura J V Piddock
Journal:  J Antimicrob Chemother       Date:  2011-12-20       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.